Mahamet GP 2mg/500mg/15mg Tablet SR
Marketer
Elgoog Health Series
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Mahamet GP 2mg/500mg/15mg Tablet SR
Glyciphage XR 2mg/500mg/15mg tablets are a combined medication formulated to manage blood glucose. This medication, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, resulting in reduced blood sugar. Always adhere to your physician's prescribed dosage and regimen for Glyciphage XR 2mg/500mg/15mg tablets. Take it with food to prevent gastrointestinal discomfort. If a dose is missed, take it immediately; however, if the next dose is imminent, omit the missed one and resume your usual schedule. Never double the dose. Overdosage can cause hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol, or skipped meals may increase the risk of hypoglycemia. Regular blood sugar monitoring is crucial during treatment. Common adverse effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or breastfeeding individuals should seek medical counsel before use. Kidney function tests will be performed before treatment initiation. Limit alcohol consumption as it may exacerbate side effects.
Primary Ingredients of Mahamet GP 2mg/500mg/15mg Tablet SR
No text provided. Please provide the text you would like me to rephrase.
Uses of Mahamet GP 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Mahamet GP 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Mahamet GP 2mg/500mg/15mg Extended-Release tablet should be administered with a meal.
Common Side effects of Mahamet GP 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Mahamet GP 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. The Mahamet GP 2mg/500mg/15mg Extended-Release tablet should be administered with a meal.
How Mahamet GP 2mg/500mg/15mg Tablet SR works:
Mahamet GP SR tablets (2mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. These medications act via separate pathways to optimize blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose. Metformin, a biguanide, decreases hepatic glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Mahamet GP 2mg/500mg/15mg SR Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Mahamet GP 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Mahamet GP 2mg/500mg/15mg tablet likely poses a risk during lactation. Scant evidence from humans indicates potential transfer to breast milk with the possibility of infant harm.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Mahamet GP 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. For those with severe kidney disease, this medication is contraindicated. Regular kidney function tests are recommended during treatment.
LiverCAUTION
Patients with liver impairment should use the extended-release Mahamet GP 2mg/500mg/15mg tablet cautiously, as dosage modification may be necessary. Individuals with severe hepatic dysfunction should avoid this medication; consult a physician for guidance.
What if you forget to take Mahamet GP 2mg/500mg/15mg Tablet SR :
Should you forget a dose of Mahamet GP 2mg/500mg/15mg SR Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mahamet GP 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently